AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 46 min read$WAT

Waters Corporation (NYSE:WAT) Exceeds Q2 CY2026 Expectations

Waters Corporation (NYSE:WAT) reported Q2 CY2026 revenue of $1.65 billion, up 113% year on year and 1.3% above estimates, with non-GAAP EPS of $3.05, 1.4% above consensus. It guided next-quarter revenue around $1.75 billion and expects 119% YoY growth. Adjusted operating margin fell to -3.7%.

Original reporting
financialcontent.com
Published Aug 4, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 12:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Waters Corporation (NYSE:WAT) Exceeds Q2 CY2026 Expectations — source image
Source · financialcontent.com
Decision brief

The 30-second read

$WATBullishMed
01

Why it matters

Traders can use the reported Q2 beat and the next-quarter revenue guidance to update near-term expectations, but should weigh the large adjusted operating margin contraction as a potential driver of multiple compression.

02

Market read

A company-specific earnings and guidance update with explicit revenue, EPS, and margin details that can drive short-term positioning.

03

What to watch

Adjusted operating margin fell to negative 3.7% and guidance is only “close to estimates,” so the market may re-rate the stock on efficiency rather than growth.

Relevance 8/10Novelty 7/10Timing: published on Q2 results day, with next-quarter revenue guidance

Background

Waters is a scientific instruments company serving liquid chromatography, mass spectrometry, and related consumables/software markets.

Company-level read

Ticker impact

$WATBullishMedium confidence
Context

Waters reported Q2 CY2026 revenue of $1.65B, up 113% year over year, and guided next-quarter revenue to about $1.75B.

Expected impact

Near-term upside bias versus estimates, but expect choppy trading if investors focus on the sharp adjusted operating margin deterioration.

Evidence & confidence

The article provides concrete Q2 results (revenue and adjusted EPS beats) plus explicit next-quarter revenue guidance, while also highlighting a large year-over-year adjusted operating margin decline and negative margin in the quarter.

Market effects

Sector

Signals demand strength for analytical instruments and services, but profitability pressure may raise caution across instrument peers.

Regional

No specific regional catalyst beyond US-listed earnings reaction.

Global

Limited; impacts are primarily company-specific within life sciences tools.

Counterpoint

What could challenge this read

The headline revenue surge may be influenced by mix, acquisitions, or FX, while profitability deteriorated sharply, suggesting quality-of-earnings risk.

Key entities

  • company
    Waters Corporation

    Reported Q2 CY2026 revenue and adjusted EPS, and provided next-quarter revenue guidance.

  • executive
    Udit Batra, Ph.D.

    President and CEO who commented on delivering growth ahead of guidance.

Read at source← All news

Related articles

AUG 6
$WATMedAI 8/10

Waters Corporation Q2 2026 Earnings Call Summary

Waters Corp reported 9% organic constant-currency growth in Q2 2026, citing strength in pharma and academic end markets and a 400 bps growth acceleration in newly acquired Biosciences and Diagnostic Solutions. The company raised 2026 organic revenue guidance to 7-9%, expects acquired businesses to exit 2026 at 6%+ growth, and projects mid-teens adjusted EPS growth with margin expansion.

yahoo.com7 min
AUG 4
$WATHighAI 8/10

Why Waters Corporation (WAT) Stock Is Trading Up Today

Waters Corp (NYSE:WAT) shares rose about 5% after the company reported Q2 results that beat Wall Street and lifted full-year guidance. Waters posted adjusted EPS of $3.05 on revenue of $1.65B, with 7% organic growth. The company now expects 2026 adjusted earnings around $14.55 per share at the midpoint.

stockstory.org4 min
AUG 4
$WATMedAI 9/10

Waters Posts Loss In Q2; Raises 2026 Guidance

Waters Corporation (NYSE: WAT) reported a Q2 net loss of $136 million, versus net income of $147 million a year earlier. The company said Q2 GAAP results included non-GAAP EPS of $3.05 and revenue of $1.645 billion, above its guidance range. Waters also raised its 2026 guidance, according to its filings.

finanznachrichten.de4 min
AUG 4
$WATMedAI 8/10

Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results

Waters Corp (NYSE: WAT) reported Q2 2026 revenue of $1.645B, above guidance, with $828M organic revenue (+7% reported, +9% constant currency) and $817M from acquired Biosciences and Diagnostic Solutions. Adjusted EPS was $3.05 (high end of guidance); GAAP EPS was -$1.39. Waters raised full-year 2026 guidance: organic constant-currency growth 7% to 9% and adjusted EPS $14.45 to $14.65.

finanznachrichten.de6 min